Stockscreener 앱 받기
42.60
0.33%
0.14
시간 외 거래:
42.60
전일 마감가:
$42.46
열려 있는:
$42.4
하루 거래량:
866.45K
Relative Volume:
0.61
시가총액:
$2.61B
수익:
$362.27M
순이익/손실:
$-85.19M
주가수익비율:
-29.38
EPS:
-1.45
순현금흐름:
$-68.71M
1주 성능:
+2.28%
1개월 성능:
+28.90%
6개월 성능:
+18.37%
1년 성능:
-18.44%
1일 변동 폭
$41.78
$43.34
1주일 범위
$41.30
$45.76
52주 변동 폭
$23.30
$54.74
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
TWST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
42.60 | 2.60B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
623.91 | 235.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.75 | 167.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
694.75 | 55.72B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.04 | 40.77B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.95 | 38.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-04 | 개시 | Stephens | Overweight |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-06-04 | 개시 | Guggenheim | Buy |
| 2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-27 | 개시 | Berenberg | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-29 | 개시 | William Blair | Outperform |
| 2021-06-04 | 개시 | Goldman | Neutral |
| 2021-04-12 | 개시 | Piper Sandler | Overweight |
| 2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
| 2019-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
cathie wood’s ARK stock trades: bullish and kodiak ai bought, kratos defense and twist bioscience sold - Investing.com South Africa
Cathie Wood Dumps Biotech Stocks, Loads Up on AI and Self-Driving Companies - CoinCentral
Cathie Wood’s ARK sells Twist Bioscience stock, buys Tempus AI and WeRide - Investing.com
Guggenheim Raises Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Twist Bioscience (TWST) Projected to Post Earnings on Monday - MarketBeat
Laponis, Twist Bioscience CFO, sells $120k in shares By Investing.com - Investing.com Nigeria
Laponis, Twist Bioscience CFO, sells $120k in shares - Investing.com
Insider Sell: Adam Laponis Sells 3,000 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Finn, Twist Bioscience COO, sells $931k in TWST stock - Investing.com
Finn, Twist Bioscience COO, sells $931k in TWST stock By Investing.com - Investing.com Canada
Twist Bioscience president Finn sells $140,406 in stock - MSN
Twist Bioscience Corporation (TWST): Investor Outlook Reveals 16.9% Revenue Growth and Bullish Analyst Ratings - DirectorsTalk Interviews
Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results - TechStock²
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue - Chartmill
Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook - Yahoo! Finance Canada
Twist Bioscience Corporation $TWST Shares Acquired by Peregrine Capital Management LLC - MarketBeat
Analyst Brendan Smith Maintains "Buy" on Twist Bioscience (TWST), Raises Price Target | TWST Stock News - GuruFocus
Twist Bioscience Corp ($TWST) CEO and COB 2025 Pay Revealed - Quiver Quantitative
Form ARS Twist Bioscience Corp For: Sep 30 - StreetInsider
Twist Bioscience (NASDAQ:TWST) Trading 7.4% HigherShould You Buy? - MarketBeat
Twist Bioscience Corporation (TWST) Stock Analysis: Unpacking a 10.29% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
Cathie Wood’s ARK buys Beam and Twist Bioscience stocks, sells Roku - Investing.com India
Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) - Insider Monkey
Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 9.21% Potential Upside in Synthetic DNA Innovation - DirectorsTalk Interviews
Cathie Wood’s ARK makes strategic stock moves, buys Intellia and sells Roku - Investing.com
Twist Bioscience2025 Funding Rounds & List of Investors - Tracxn
Twist Bioscience Corporation (NASDAQ:TWST) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells 1,605 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) Stock Price Down 4.1%Time to Sell? - MarketBeat
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST) - Finviz
Twist Bioscience (TWST) Stock News Today: Forecasts, Analyst Targets, and Key Catalysts (Dec. 22, 2025) - ts2.tech
What valuation multiples suggest for Twist Bioscience Corporation stock2025 Price Targets & Low Risk High Reward Trade Ideas - Улправда
Will Twist Bioscience Corporation (0ME) stock remain on Wall Street radarTrade Ideas & Verified Swing Trading Watchlist - Улправда
Is Twist Bioscience Corporation (0ME) stock a contrarian opportunityPortfolio Growth Summary & Weekly Chart Analysis and Guides - DonanımHaber
Published on: 2025-12-18 20:43:14 - Улправда
Twist Bioscience (TWST): Evaluating Valuation After New Research‑Grade Plasmid DNA Preps Launch - simplywall.st
Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference - Business Wire
Squarepoint Ops LLC Raises Stock Position in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience (NASDAQ:TWST) Trading Up 6.4%Should You Buy? - MarketBeat
Twist Bioscience (TWST) Stock News Today: Latest Catalysts, Analyst Forecasts, and 2026 Outlook (Dec. 17, 2025) - ts2.tech
Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a Potential 15% Upside for Forward-Thinking Investors - DirectorsTalk Interviews
Aptamer Group Signs First Licensing Deal With Twist Bioscience - DirectorsTalk Interviews
Aptamer Group PLCLicensing agreement with Twist Bioscience - Research Tree
Aptamer Group signs licensing deal with Twist Bioscience for NGS market - Investing.com Canada
Barclays Raises Price Target for Twist Bioscience (TWST) to $39 - GuruFocus
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
0.21%
자본화:
|
볼륨(24시간):